Skip to main content
Fibroblast variants nonresponsive to fibroblast growth factor 1 are defective in its nuclear translocation
Journal of Biological Chemistry (1998)
  • V Mehta
  • L Connors
  • Hwa-Chain Robert Wang, University of Tennessee, Knoxville
  • I M Chiu
Fibroblast growth factors (FGF) elicit biological effects by binding to high affinity cell-surface receptors and activation of receptor tyrosine kinase. We previously reported that two NIH/3T3 derivatives, NR31 and NR33 (NR cells), express high levels of full-length FGF-1 and exhibit a complete spectrum of transformed phenotype. In the present study, we report that NR cells respond to the mitogenic stimulation of truncated FGF-1 but not to the full-length FGF-1. Incubation of the NR cells with either form of FGF-1 resulted in its binding to cell-surface FGF receptors, activation of mitogen-activated protein (MAP) kinase, and induction of c-fos and c-myc. These data demonstrate that the FGF receptor-mediated, MAP kinase-dependent signaling pathway is not defective in the NR cells. Our data further suggest that the activation of MAP kinase in response to full-length FGF-1 is not sufficient for mitogenesis. Subcellular distribution of exogenously added FGF-1 demonstrated that full-length FGF-1 fails to translocate to the nuclei of NR31 cells. Although the full-length FGF-1 was detected in the nuclear fractions of both NIH/3T3 and NR33 cells, its half-life is much shortened in NR33 than in NIH/3T3 cells. These observations suggest that non-responsiveness of the two NR cell lines may be due to defectiveness at different steps of nuclear translocation mechanism of FGF-1.
Publication Date
Citation Information
V Mehta, L Connors, Hwa-Chain Robert Wang and I M Chiu. "Fibroblast variants nonresponsive to fibroblast growth factor 1 are defective in its nuclear translocation" Journal of Biological Chemistry Vol. 273 Iss. 7 (1998)
Available at: